• News

Multiomics Used To Stratify Multiple Myeloma Patients Into Affinity Groups

  • Clinical Research News
  • New York, NY
  • (January 06, 2022)

Alessandro Lagana, PhD, discusses his study with multiple myeloma patients now being assigned to one of 12 subgroups based on shared genetic and molecular features of their disease, one of the latest computational modeling tools being used to translate clinical data into better treatment decision-making in the clinic, and the first to apply multiomics to patients with the blood cancer.

Read More